← Back to Search

Other

RapidShock for Cardiac Arrest

N/A

Waitlist Available

Research Sponsored by Zoll Medical Corporation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Non-traumatic cardiac arrest

8 years of age or older and weight ≥ 55 lbs (25 kgs)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up average of up to 1 hour after device placement

Awards & highlights

Study Summary

This trial found that the Reconfirmation Analysis Mode algorithm outperformed the American Heart Association's recommended performance goals.

Who is the study for?

This trial is for individuals aged 8 or older who weigh at least 55 lbs and have experienced a non-traumatic, out-of-hospital cardiac arrest. It's not suitable for those under the weight limit or with 'do not attempt resuscitation' orders.Check my eligibility

What is being tested?

The study is evaluating RapidShock, specifically its Reconfirmation Analysis Mode algorithm, against performance goals set by the American Heart Association in real-world use during cardiac arrests.See study design

What are the potential side effects?

As this trial involves a device used during emergency cardiac events, side effects are related to its performance rather than typical drug reactions and may include potential issues with accurate analysis of heart rhythm.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I experienced a sudden heart stoppage not caused by an injury.

Select...

I am at least 8 years old and weigh 55 lbs or more.

Select...

I had a cardiac arrest outside of a hospital.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ average of up to 1 hour after device placement

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~average of up to 1 hour after device placement

This trial's timeline: 3 weeks for screening, Varies for treatment, and average of up to 1 hour after device placement for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Algorithm accuracy

Trial Design

1Treatment groups

Experimental Treatment

Group I: RapidShockExperimental Treatment1 Intervention

Patients receiving xseries device with rapid shock enabled

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Zoll Medical CorporationLead Sponsor

41 Previous Clinical Trials

19,571 Total Patients Enrolled

3 Trials studying Cardiac Arrest

9,731 Patients Enrolled for Cardiac Arrest

Media Library

RapidShock (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04014842 — N/A

Cardiac Arrest Research Study Groups: RapidShock

Cardiac Arrest Clinical Trial 2023: RapidShock Highlights & Side Effects. Trial Name: NCT04014842 — N/A

RapidShock (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04014842 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many centers are responsible for administering this clinical trial?

"Currently, the Colorado Springs Fire Department in Colorado Springs, Broward County Sheriff's Office Fire Rescue in Fort Lauderdale and East Baton Rouge Parish EMS in Baton Rouge are trialing this medication. Additionally, 7 other test centers have been identified for patient enrolment."

Answered by AI

Is this clinical experiment currently taking applications from participants?

"The clinicaltrials.gov database indicates that this trial, which was created on February 26th 2019 and revised most recently on January 21st 2022, is not recruiting participants at the moment; however, 66 other medical studies are enrolling patients as of now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

RapidShock Post-Approval Study

2019. "RapidShock Post-Approval Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04014842.

All > Cardiac Arrest